Skip to main content

Collins Kevin Walter's Form 4 filing

Lucira Health, Inc. (LHDX) · filed Nov 29, 2022

Accession no.
0001209191-22-058925
Filed
Nov 29, 2022, 12:08 PM ET
Trade date
Nov 27, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $4.06K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Collins Kevin WalterCIK 0001870312Officer (Chief Revenue Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 27, 2022Common StockSSaleDisposed−9,666$0.42−$4,059.72346,722Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)